All NYU Grossman School of Medicine articles
-
NewsBig data study finds RSV vaccine highly effective in protecting older adults
A multi-state study, published in The Lancet, is one of the first real world data analyses of the effectiveness of the RSV (respiratory syncytial virus) vaccine. VISION Network researchers report that across the board these vaccines were highly effective in older adults, even those with immunocompromising conditions, during the 2023-24 ...
-
NewsNew tool reveals gene behavior in bacteria
Researchers showed that the way in which genes are turned on and off as bacteria grow provide clues to their regulation.
-
NewsExperiments in infant mice suggest new way to prevent spread of flu in people
A new study in infant mice shows that keeping virus particles from attaching to sialic acids limits more than just the entry of influenza A viral infections, but also hinders their exit (shedding) and transmission from mouse to mouse.
-
NewsMpox vaccine triggers equally strong immune response in smaller doses
Delivering the two-dose mpox vaccine in smaller than the usual FDA-approved doses produced a detectable immune response. This also occurred regardless of whether people were living with or without HIV.
-
NewsNewly engineered versions of bacterial enzyme reveal how antibiotics could be more potent
Researchers have generated the full inventory of mutations in the bacterial species Escherichia coli where the antibiotic rifampicin attaches to and disables an essential bacterial enzyme known as RNA polymerase (RNAP).
-
NewsLupus flare-ups linked to Ruminococcus blautia gnavus blooms in gut
A new study found that bacterial blooms of the gut bacterium Ruminococcus blautia gnavus occurred at the same time as disease flare-ups in five of 16 women with lupus of diverse racial backgrounds studied over a four-year period.
-
NewsNew biologic effective against major infection in early tests
Researchers have shown in early tests that a bioengineered drug candidate can counter infection with Staphylococcus aureus – a bacterial species widely resistant to antibiotics and a major cause of death in hospitalized patients.
-
NewsCOVID-19 virus increases risk of other infections by disrupting normal mix of gut bacteria
Infection with Covid-19 can reduce the number of bacterial species in a patient’s gut, with the lesser diversity creating space for dangerous microbes to thrive, a new study has found.
